Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
| $28M | ﹤0.01% |
784,532
+104,926
| +15% | +$3.75M |
|
2352
First Trust Nasdaq Bank ETF
FTXO
$316M
| $27.8M | ﹤0.01% |
913,883
+310,602
| +51% | +$10.1M |
|
2353
Seadrill
SDRL
$2.92B
| $27.8M | ﹤0.01% |
1,110,911
-137,971
| -11% | -$4.27M |
|
|
PPBI
2354
DELISTED
Pacific Premier Bancorp
PPBI
| $27.8M | ﹤0.01% |
1,302,072
-142,561
| -10% | -$3.4M |
|
2355
Rigel Pharmaceuticals
RIGL
$778M
| $27.7M | ﹤0.01% |
1,536,987
-24,509
| -2% | -$497K |
|
2356
Omnicell
OMCL
$1.7B
| $27.6M | ﹤0.01% |
790,779
-82,672
| -9% | -$3.28M |
|
2357
Fulton Financial
FULT
$4.6B
| $27.6M | ﹤0.01% |
1,527,949
-243,683
| -14% | -$4.75M |
|
2358
SiriusPoint
SPNT
$2.63B
| $27.6M | ﹤0.01% |
1,598,109
+49,241
| +3% | +$734K |
|
2359
IDEAYA Biosciences
IDYA
$3.54B
| $27.6M | ﹤0.01% |
1,686,588
+131,508
| +8% | +$2.8M |
|
|
UCB
2360
United Community Banks
UCB
$4.27B
| $27.6M | ﹤0.01% |
981,665
-115,077
| -10% | -$3.6M |
|
2361
Coca-Cola Femsa
KOF
$22.9B
| $27.6M | ﹤0.01% |
302,037
-29,350
| -9% | -$2.43M |
|
2362
IPG Photonics
IPGP
$3.61B
| $27.6M | ﹤0.01% |
436,347
+18,121
| +4% | +$1.22M |
|
2363
Innovative Industrial Properties
IIPR
$1.66B
| $27.5M | ﹤0.01% |
509,294
+76,921
| +18% | +$5.33M |
|
2364
Skyward Specialty Insurance
SKWD
$2.51B
| $27.5M | ﹤0.01% |
520,542
-56,164
| -10% | -$2.71M |
|
2365
EPR Properties
EPR
$4.63B
| $27.5M | ﹤0.01% |
523,080
-114,613
| -18% | -$5.62M |
|
2366
Establishment Labs
ESTA
$2.21B
| $27.5M | ﹤0.01% |
673,181
-147,944
| -18% | -$5.52M |
|
2367
Progyny
PGNY
$2.18B
| $27.4M | ﹤0.01% |
1,228,221
-1,206,643
| -50% | -$26M |
|
2368
Scholar Rock
SRRK
$6.32B
| $27.4M | ﹤0.01% |
853,437
+440,052
| +106% | +$16.9M |
|
2369
Haemonetics
HAE
$3.94B
| $27.4M | ﹤0.01% |
431,596
-65,976
| -13% | -$4.49M |
|
2370
Mach Natural Resources
MNR
$2.2B
| $27.4M | ﹤0.01% |
1,761,775
+1,358,647
| +337% | +$21.9M |
|
|
DIAX
2371
DELISTED
Nuveen Dow 30SM Dynamic Overwrite Fund
DIAX
| $27.4M | ﹤0.01% |
1,890,566
+7,197
| +0.4% | +$108K |
|
2372
PagerDuty
PD
$916M
| $27.4M | ﹤0.01% |
1,499,177
-669,332
| -31% | -$12.3M |
|
2373
Yeti Holdings
YETI
$3.99B
| $27.4M | ﹤0.01% |
826,872
-596,271
| -42% | -$21.6M |
|
2374
Mirum Pharmaceuticals
MIRM
$6.02B
| $27.3M | ﹤0.01% |
606,431
-151,949
| -20% | -$7.16M |
|
2375
WPP
WPP
$5.76B
| $27.3M | ﹤0.01% |
719,056
-71,379
| -9% | -$3.18M |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.